Novel drug raises hope for patients with advanced melanomaJune 2nd, 2009 - 2:49 pm ICT by ANI
London, June 2 (ANI): A drug that can treat the most deadly form of skin cancer in its most advanced, incurable stages has been created by scientists.
According to early trial results, an experimental drug PLX4032 (R7204) could help many patients with malignant melanoma live longer with the disease in check.
The novel drug works by seeking out and destroying tumour cells carrying the BRAF mutation implicated in 60 percent malignant melanomas. This could not only help to shrink the skin cancer, but also delay its spread.
In a phase I study, which involved 16 patients with BRAF-positive melanoma, over half saw the extent of their cancer reduce by at least 30 percent, reports The BBC.
Patients treated with PLX4032 lived for a median of six months without their disease getting worse and more than half experienced significant shrinkage of their tumours.
Roche and its partner Plexxikon told delegates at the American Society of Clinical Oncology meeting that they are planning larger trials to further test the drug’s safety.
Dr Jodie Moffat of Cancer Research UK said: “While these results are interesting, they need to be followed up in much larger studies before we know if this is a suitable new treatment for people with advanced melanoma.
“Melanoma is difficult to treat when it is at an advanced stage so it’s crucial to find new treatments to help beat the disease.
“When melanoma is diagnosed early, treatment is often simpler and more likely to be effective. If you notice a change in the size, shape or colour of a mole or other patch of skin, make sure you get it checked out by your doctor without delay.
“Excessive exposure to ultraviolet radiation, from the sun or from sunbeds, is the leading cause of skin cancer.” (ANI)
- Skin cancer pill shrinks tumour in 80 percent cases - Aug 26, 2010
- Skin cancer pill showing 'remarkable' results, say researchers - Aug 26, 2010
- Pill to fight deadly skin cancer in sight - Jan 20, 2011
- New hope in the fight against melanoma - Dec 14, 2010
- Arthritis drug could help treat skin cancer - Mar 24, 2011
- 'Spectacular' treatment for skin cancer developed - Sep 24, 2009
- 'Penicillin' breakthrough in cancer treatment? - Sep 15, 2010
- California scientists hail 'penicillin moment' in cancer treatment - Sep 15, 2010
- New pills shrink cancer tumours by half - Jul 24, 2010
- Scientists complete whole-exome sequencing of skin cancer - Apr 16, 2011
- Zebrafish offers skin cancer clues - Apr 06, 2011
- Cure cancer in just two hours - Jan 06, 2012
- Vaccine offers hope against deadly skin cancer - May 27, 2010
- Drug discovery combats ovarian cancer - Jun 05, 2011
- How melanoma tumours evade drug treatment - Nov 25, 2010
Tags: cancer research uk, cause of skin cancer, clinical oncology meeting, delegates, excessive exposure, experimental drug, malignant melanoma, melanoma, moffat, mole, mutation, novel drug, oncology, roche, shrinkage, size shape, skin cancer, tumour cells, tumours, ultraviolet radiation